Sumeet Mody

Stock Analyst at Piper Sandler

(4.8)
# 146
Out of 5,393 analysts
54
Total ratings
Success rate
Average return
13 Stocks
Name Action PT Current % Upside Ratings Updated
ENFN Enfusion
Maintains: Neutral
10 12
10.76 6.88% 4 Dec 23, 2024
SEIC SEI Inv
Maintains: Neutral
58 66
92.95 -28.99% 4 Dec 20, 2023
GCMG GCM Grosvenor
Maintains: Overweight
9 10
11.68 -14.38% 2 Aug 10, 2023
KKR KKR & Co
Maintains: Overweight
59 70
138.4 -49.42% 4 Aug 8, 2023
BX Blackstone
Maintains: Overweight
107 115
154.67 -25.65% 7 Jul 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
21 13
10.22 27.2% 1 May 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
17 15
19.77 -24.13% 3 May 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
35 38
65.03 -41.57% 6 Apr 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
248 260
198.26 31.14% 11 Mar 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
21 23
16.53 39.14% 5 Mar 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
86 97
177.72 -45.42% 2 Feb 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
58 48
55.69 -13.81% 1 Feb 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
55 58
38.99 48.76% 4 May 2, 2022